What it is
Partial reprogramming applies the four “Yamanaka factors” — the genes that can turn an adult cell back into a stem cell — but only briefly, aiming to reset signs of ageing while keeping the cell's identity. It is a leading approach in the broader field of cellular rejuvenation.
Why it matters for longevity
In animals, cyclic partial reprogramming has reversed markers of ageing, restored function in some tissues (for example the eye) and, in certain models, extended lifespan. It directly targets the epigenetic-alterations hallmark and can lower epigenetic clock age.
What the evidence shows
This is Experimental. The results are striking but almost entirely preclinical, and the central risk is serious: the same factors, pushed too far, can cause cancer (teratomas). There is no approved human therapy.
Bottom line
One of the most exciting areas in longevity science — and one where consumer offerings claiming “reprogramming” run far ahead of the safety and efficacy evidence.